Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · IEX Real-Time Price · USD

2.740

-0.730 (-21.04%)

At close: Jul 2, 2024, 4:00 PM

2.890

+0.150 (5.47%)

After-hours: Jul 2, 2024, 7:37 PM EDT

Heron Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	-110.56	-182.02	-220.68	-227.28	-204.75	Upgrade
Depreciation & Amortization	2.9	2.89	3.02	2.85	2.04	Upgrade
Share-Based Compensation	32.85	42.98	46.85	50.22	51.41	Upgrade
Other Operating Activities	16.02	-10.76	-32.54	-10.61	26.71	Upgrade
Operating Cash Flow	-58.79	-146.91	-203.35	-184.82	-124.58	Upgrade
Capital Expenditures	-1.53	-1.6	-2.99	-6.81	-7.15	Upgrade
Change in Investments	19.53	-1.73	35.72	215.77	-14.63	Upgrade
Investing Cash Flow	18	-3.32	32.73	208.96	-21.78	Upgrade
Share Issuance / Repurchase	29.76	75.06	7.07	9.08	186.43	Upgrade
Debt Issued / Paid	24.35	0	148.96	0.03	0	Upgrade
Financing Cash Flow	54.11	75.06	156.03	9.11	186.43	Upgrade
Net Cash Flow	13.31	-75.18	-14.6	33.24	40.06	Upgrade
Free Cash Flow	-60.32	-148.51	-206.34	-191.63	-131.73	Upgrade
Free Cash Flow Margin	-47.48%	-137.93%	-238.97%	-216.20%	-90.25%	Upgrade
Free Cash Flow Per Share	-0.44	-1.36	-2.10	-2.11	-1.61	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).